Mots-clés
![]() corrélation génotype-phénotypeSynonyme(s)genotype-phenotype correlationVoir aussi |
Documents disponibles dans cette catégorie (1134)
| Mettre toutes les notices dans le panier | Faire une suggestion | Ajouter un critère de recherche
Etendre la recherche sur niveau(x) vers le bas
![]()
Article
Velez-Bartolomei F ; Lee C ; Enns G | 07/01/2021Initial Posting: June 3, 2003; Last Update: January 7, 2021. Clinical characteristics. MERRF (myoclonic epilepsy with ragged red fibers) is a multisystem disorder characterized by myoclonus (often the first symptom) followed by generalized[...]![]()
Article
Prior TW ; Leach ME ; Finanger E | 3/12/2020Initial Posting: February 24, 2000; Last Revision: December 3, 2020. Clinical characteristics. Spinal muscular atrophy (SMA) is characterized by muscle weakness and atrophy resulting from progressive degeneration and irreversible loss of t[...]![]()
Article
Bird TD | 29/10/2020Initial Posting: September 17, 1999; Last Revision: October 29, 2020. Clinical characteristics. Myotonic dystrophy type 1 (DM1) is a multisystem disorder that affects skeletal and smooth muscle as well as the eye, heart, endocrine system, [...]![]()
Article
Trollet C ; Boulinguiez A ; Roth F ; Stojkovic T ; Butler-Browne G ; Evangelista T ; Lacau St Guily J ; Richard P | 22/10/2020Initial Posting: March 8, 2001; Last Update: October 22, 2020. Clinical characteristics. Oculopharyngeal muscular dystrophy (OPMD) is characterized by ptosis and dysphagia due to selective involvement of the muscles of the eyelids and phar[...]![]()
Article
McCray BA ; Schindler A ; Hoover-Fong JE ; Sumner CJ | 17/09/2020Initial Posting: May 15, 2014; Last Update: September 17, 2020. Clinical characteristics. The autosomal dominant TRPV4 disorders (previously considered to be clinically distinct phenotypes before their molecular basis was discovered) are n[...]![]()
Article
Initial Posting: April 2, 2009; Last Update: September 17, 2020. Clinical characteristics. Most individuals with classic GBE1 adult polyglucosan body disease (GBE1-APBD) present after age 40 years with unexplained progressive neurogenic bl[...]![]()
Article
Oliveira J ; Parente Freixo J ; Santos M ; Coelho T | 17/09/2020Initial Posting: June 7, 2012; Last Update: September 17, 2020. Clinical characteristics. The clinical manifestations of LAMA2 muscular dystrophy (LAMA2-MD) comprise a continuous spectrum ranging from severe congenital muscular dystrophy t[...]![]()
Article
Chrestian N | 27/08/2020Initial Posting: September 28, 1998; Last Update: August 27, 2020. Clinical characteristics. Hereditary neuropathy with liability to pressure palsies (HNPP) is characterized by recurrent acute sensory and motor neuropathy in a single or mu[...]![]()
Article
Ferreira C ; Pierre G ; Thompson R ; Vernon H | 09/07/2020nitial Posting: October 9, 2014; Last Update: July 9, 2020. Clinical characteristics. Barth syndrome is characterized in affected males by cardiomyopathy, neutropenia, skeletal myopathy, prepubertal growth delay, and distinctive facial ges[...]![]()
Article
Prasun P | 18/06/2020Clinical characteristics. Multiple acyl-CoA dehydrogenase deficiency (MADD) represents a clinical spectrum in which presentations can be divided into type I (neonatal onset with congenital anomalies), type II (neonatal onset without congenita[...]![]()
Article
Züchner S | 14/05/2020Initial Posting: February 18, 2005; Last Update: May 14, 2020. Clinical characteristics. MFN2 hereditary motor and sensory neuropathy (MFN2-HMSN) is a classic axonal peripheral sensorimotor neuropathy, inherited in either an autosomal domi[...]![]()
Article
Sullivan JM ; Motley WW ; Johnson JO ; Aisenberg WH ; Marshall KL ; Barwick KE ; Kong L ; Huh JS ; Saavedra-Rivera PC ; McEntagart MM ; Marion MH ; Hicklin LA ; Modarres H ; Baple EL ; Farah MH ; Zuberi AR ; Lutz CM ; Gaudet R ; Traynor BJ ; Crosby AH ; Sumner CJ | United States | 03/2020![]()
Article
Preston MK ; Tawil R ; Wang LH | 06/02/2020Initial Posting: March 8, 1999; Last Update: February 6, 2020. Clinical characteristics. Facioscapulohumeral muscular dystrophy (FSHD) typically presents with weakness of the facial muscles, the stabilizers of the scapula, or the dorsiflexor[...]![]()
Article
![]()
Article
![]()
Article
Lee HH ; Wong S ; Sheng B ; Pan NK ; Leung YF ; Lau KD ; Cheng YS ; Ho LC ; Li R ; Lee CN ; Tsoi TH ; Cheung YN ; Fu YM ; Kan NA ; Chu YP ; Au WL ; Yeung HJ ; Li SH ; Cheung CM ; Tong HF ; Hung LE ; Chan TY ; Li CT ; Tong TT ; Tong TC ; Leung HC ; Lee KH ; Yeung SS ; Lee SB ; Lau TG ; Lam CW ; Mak CM ; Chan AY | Denmark | 02/2020![]()
Article
Zanoteli E ; Soares PS ; Silva AMSD ; Camelo CG ; Fonseca ATQSM ; Albuquerque MAV ; Moreno CAM ; Lopes Abath Neto O ; Novo Filho GM ; Kulikowski LD ; Reed UC | Netherlands | 02/2020![]()
Article
Frasquet M ; Camacho A ; Vilchez R ; Argente-Escrig H ; Millet E ; Vazquez-Costa JF ; Silla R ; Sánchez-Monteagudo A ; Vilchez JJ ; Espinos C ; Lupo V ; Sevilla T | England | 02/2020![]()
Article
![]()
Article
![]()
Article
![]()
Article
Ishihara S ; Okamoto Y ; Tanabe H ; Yoshimura A ; Higuchi Y ; Yuan JH ; Hashiguchi A ; Ishiura H ; Mitsui J ; Suwazono S ; Oya Y ; Sasaki M ; Nakagawa M ; Tsuji S ; Ohya Y ; Takashima H | United States | 02/2020![]()
Article
Rosenberg H ; Sambuughin N ; Riazi S ; Dirksen R | 16/01/2020Initial Posting: December 19, 2003; Last Update: January 16, 2020. Clinical characteristics. Malignant hyperthermia susceptibility (MHS) is a pharmacogenetic disorder of skeletal muscle calcium regulation associated with uncontrolled skeleta[...]![]()
Article
Pellerin D ; Aykanat A ; Ellezam B ; Troiano EC ; Karamchandani J ; Dicaire MJ ; Petitclerc M ; Robertson R ; Allard-Chamard X ; Brunet D ; Konersman CG ; Mathieu J ; Warman Chardon J ; Gupta VA ; Beggs AH ; Brais B ; Chrestian N | United States | 01/2020